|
Median age (IQR)
|
56 (46–61)
|
52 (41–58)
|
|
Sex–male
|
101 (72%)
|
23 (70%)
|
|
Ethnicity
|
|
White
|
49 (35%)
|
16 (47%)
|
|
Black and minority ethnicities
|
74 (52%)
|
15 (44%)
|
|
Not known
|
19 (13%)
|
3 (9%)
|
|
Mortality
|
34 (25%)
|
8 (24%)
|
|
Length of stay (IQR)
|
25 days (15–45)
|
32 days (24–47)
|
|
Respiratory cultures in ICUb
|
|
Median samples per patient (IQR)
|
2 (1–3)
|
4 (4–6)
|
|
Total number of samples/patients tested
|
372/117
|
180/34
|
|
Organisms from respiratory culture whilst in ICU (number of individuals who ever had the following organisms in any sample)
|
|
Klebsiella spp.
|
48 (34%)
|
18 (53%)
|
|
Staphylococcus aureus
|
14 (10%)
|
3 (9%)
|
|
Citrobacter spp.
|
14 (10%)
|
5 (15%)
|
|
Escherichia coli
|
7 (5%)
|
3 (9%)
|
|
Pseudomonas spp.
|
10 (7%)
|
1 (3%)
|
|
Corynebacterium striatum
|
8 (6%)
|
8 (24%)
|
|
Enterococcus spp.
|
12 (9%)
|
4 (12%)
|
|
Serratia spp.
|
9 (6%)
|
2 (6%)
|
|
Enterobacter spp.
|
6 (4%)
|
1 (3%)
|
|
Haemophilus spp.
|
2 (1%)
|
0 (0%)
|
|
Stenotrophomonas maltophilia
|
4 (3%)
|
1 (3%)
|
|
Proteus spp.
|
0 (0%)
|
4 (12%)
|
|
Morganella spp.
|
0 (0%)
|
1 (3%)
|
|
Acinetobacter spp.
|
0 (0%)
|
1 (3%)
|
|
Streptococcus pyogenes
|
3 (2%)
|
0 (0%)
|
|
Candida albicans
|
40 (28%)
|
13 (38%)
|
|
Candida spp. (non-albicans)
|
10 (7%)
|
5 (15%)
|
|
Aspergillus spp.
|
1 (1%)
|
3 (9%)
|
|
No organisms isolated
|
40 (30%)
|
2 (6%)
|
|
Galactomannans (GMs)
|
|
Bronchoalveolar lavage (BAL) GMs
|
|
Number of tests/patients tested
|
38/28
|
25/16
|
|
Positive tests/patients positive
|
0/0
|
6/5
|
|
Serum GMs
|
|
Number of tests/patients tested
|
74/50
|
34/22
|
|
Positive tests/patients positive
|
4/4
|
3/3
|
